Healthcare -
Biotechnology - NASDAQ - US
$ 3.62
-3.21 %
$ 124 M
Market Cap
-1.37
P/E
TARA - CASH & EQUIVALENTS
Cash & Equivalents TARA - Protara Therapeutics, Inc.
39.6 M
LAST VALUE
5.27%
2 YEAR CAGR
15.37%
5 YEAR CAGR
30.18%
10 YEAR CAGR